928 related articles for article (PubMed ID: 28982981)
21. Crk1/2 and CrkL play critical roles in maintaining podocyte morphology and function.
Du J; Meng L; Pang L; Jin B; Duan N; Huang C; Huang H; Li H
Exp Cell Res; 2020 Sep; 394(1):112135. PubMed ID: 32535035
[TBL] [Abstract][Full Text] [Related]
22. Genetic ablation of SLK exacerbates glomerular injury in adriamycin nephrosis in mice.
Woychyshyn B; Papillon J; Guillemette J; Navarro-Betancourt JR; Cybulsky AV
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1377-F1390. PubMed ID: 32308020
[TBL] [Abstract][Full Text] [Related]
23. BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization.
Li M; Armelloni S; Zennaro C; Wei C; Corbelli A; Ikehata M; Berra S; Giardino L; Mattinzoli D; Watanabe S; Agostoni C; Edefonti A; Reiser J; Messa P; Rastaldi MP
J Pathol; 2015 Apr; 235(5):731-44. PubMed ID: 25408545
[TBL] [Abstract][Full Text] [Related]
24. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
25. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
Kim M; Kim M; Lee S; Kuninaka S; Saya H; Lee H; Lee S; Lim DS
EMBO J; 2013 May; 32(11):1543-55. PubMed ID: 23644383
[TBL] [Abstract][Full Text] [Related]
26. Role of C/EBP-α in Adriamycin-induced podocyte injury.
Zhong F; Wang W; Lee K; He JC; Chen N
Sci Rep; 2016 Sep; 6():33520. PubMed ID: 27644413
[TBL] [Abstract][Full Text] [Related]
27. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
28. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.
Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS
Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369
[TBL] [Abstract][Full Text] [Related]
29. Glomerulosclerosis Induced by Deficiency of Membrane-Associated Guanylate Kinase Inverted 2 in Kidney Podocytes.
Shirata N; Ihara KI; Yamamoto-Nonaka K; Seki T; Makino SI; Oliva Trejo JA; Miyake T; Yamada H; Campbell KN; Nakagawa T; Mori K; Yanagita M; Mundel P; Nishimori K; Asanuma K
J Am Soc Nephrol; 2017 Sep; 28(9):2654-2669. PubMed ID: 28539383
[TBL] [Abstract][Full Text] [Related]
30. Mechanical challenges and cytoskeletal impairments in focal segmental glomerulosclerosis.
Feng D; DuMontier C; Pollak MR
Am J Physiol Renal Physiol; 2018 May; 314(5):F921-F925. PubMed ID: 29363327
[TBL] [Abstract][Full Text] [Related]
31. Inhibiting calpain 1 and 2 in cyclin G associated kinase-knockout mice mitigates podocyte injury.
Tian X; Inoue K; Zhang Y; Wang Y; Sperati CJ; Pedigo CE; Zhao T; Yan M; Groener M; Moledina DG; Ebenezer K; Li W; Zhang Z; Liebermann DA; Greene L; Greer P; Parikh CR; Ishibe S
JCI Insight; 2020 Nov; 5(22):. PubMed ID: 33208557
[TBL] [Abstract][Full Text] [Related]
32. Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.
Angeletti A; Cantarelli C; Petrosyan A; Andrighetto S; Budge K; D'Agati VD; Hartzell S; Malvi D; Donadei C; Thurman JM; Galešić-Ljubanović D; He JC; Xiao W; Campbell KN; Wong J; Fischman C; Manrique J; Zaza G; Fiaccadori E; La Manna G; Fribourg M; Leventhal J; Da Sacco S; Perin L; Heeger PS; Cravedi P
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32717081
[TBL] [Abstract][Full Text] [Related]
33. PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function.
Wilson KE; Li YW; Yang N; Shen H; Orillion AR; Zhang J
J Biol Chem; 2014 Aug; 289(34):23693-700. PubMed ID: 25023289
[TBL] [Abstract][Full Text] [Related]
34. Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway.
An Y; Zhang Q; Li X; Wang Z; Li Y; Tang X
Biomed Pharmacother; 2018 Dec; 108():1845-1855. PubMed ID: 30372890
[TBL] [Abstract][Full Text] [Related]
35. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
36. The role of the FSGS disease gene product and nuclear pore protein NUP205 in regulating nuclear localization and activity of transcriptional regulators YAP and TAZ.
Ester L; Cabrita I; Ventzke M; Kieckhöfer E; Christodoulou M; Mandel AM; Diefenhardt P; Fabretti F; Benzing T; Habbig S; Schermer B
Hum Mol Genet; 2023 Nov; 32(22):3153-3165. PubMed ID: 37565816
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.
Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR
J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856
[TBL] [Abstract][Full Text] [Related]
38. Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis.
Naves MA; Requião-Moura LR; Soares MF; Silva-Júnior JA; Mastroianni-Kirsztajn G; Teixeira VP
J Nephrol; 2012; 25(3):401-9. PubMed ID: 21928230
[TBL] [Abstract][Full Text] [Related]
39. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease.
George B; Verma R; Soofi AA; Garg P; Zhang J; Park TJ; Giardino L; Ryzhova L; Johnstone DB; Wong H; Nihalani D; Salant DJ; Hanks SK; Curran T; Rastaldi MP; Holzman LB
J Clin Invest; 2012 Feb; 122(2):674-92. PubMed ID: 22251701
[TBL] [Abstract][Full Text] [Related]
40. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.
Rogg M; Maier JI; Dotzauer R; Artelt N; Kretz O; Helmstädter M; Abed A; Sammarco A; Sigle A; Sellung D; Dinse P; Reiche K; Yasuda-Yamahara M; Biniossek ML; Walz G; Werner M; Endlich N; Schilling O; Huber TB; Schell C
J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
